Location History:
- Camarillo, CA (US) (1999 - 2005)
- Gaithersburg, MD (US) (2008 - 2018)
Company Filing History:
Years Active: 1999-2018
Title: Steven Roy Coats: Innovator in HER2 Research and Antibody Technologies
Introduction
Steven Roy Coats is an accomplished inventor based in Camarillo, California, recognized for his contributions to the field of biomedicine through his innovative patent creations. With a total of five patents to his name, Coats has made significant strides in developing novel antibody technologies aimed at treating diseases associated with HER2-mediated signal transduction.
Latest Patents
Among his latest patents, Coats is credited with the invention of bispecific HER2 antibodies. This invention involves anti-HER2 binding molecules, which include antibodies and their antigen-binding fragments. His work focuses on bispecific anti-HER2 antibodies and antibody-drug conjugates (ADCs) that specifically bind to the extracellular domain of the HER2 receptor. Additionally, he has developed pharmaceutical formulations comprising these compositions, providing methodologies for treating diseases linked to HER2-mediated signal transduction. Another notable patent relates to antibodies targeting the cyclin E2 protein, for which he disclosed nucleic acid molecules encoding cyclin E2 polypeptides, alongside methods for preparing these molecules and utilizing them in therapeutic settings.
Career Highlights
Coats has gained valuable experience working at prominent organizations such as Amgen Inc. and Medimmune Limited. His career in these esteemed companies has not only enhanced his expertise but also contributed to advancing innovative research in biopharmaceuticals.
Collaborations
Throughout his career, Coats has collaborated with notable colleagues, including Michael Brian Bass and Murray O. Robinson. These partnerships have undoubtedly enriched his research and contributed to the success of his inventions.
Conclusion
Steven Roy Coats exemplifies the spirit of innovation in biomedical research, particularly with his groundbreaking patents related to HER2 antibodies and cyclin E2 protein. His work continues to pave the way for new treatments and therapeutic strategies, showcasing the vital role of inventors in advancing medical science.